Donor selection for a second allogeneic stem cell transplantation in AML patients relapsing after a first transplant: a study of the Acute Leukemia Working Party of EBMT

Second allogeneic stem-cell transplantation (SCT2) is a therapeutic option for patients with AML relapsing after a first transplant. Prior studies have shown similar results after SCT2 from the same or different donor; however, there are limited data on second non-T-depleted haplo-identical transpla...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Blood Cancer J
Главные авторы: Shimoni, Avichai, Labopin, Myriam, Finke, Jürgen, Ciceri, Fabio, Deconinck, Eric, Kröger, Nicolaus, Gramatzki, Martin, Stelljes, Matthias, Blaise, Didier, Stoelzel, Friedrich, Chevallier, Patrice, Holler, Ernst, Fegueux, Nathalie, Mohty, Mohamad, Nagler, Arnon
Формат: Artigo
Язык:Inglês
Опубликовано: Nature Publishing Group UK 2019
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6861251/
https://ncbi.nlm.nih.gov/pubmed/31740656
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41408-019-0251-3
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы